Plant ID: NPO19592
Plant Latin Name: Michelia alba
Taxonomy Genus: Michelia
Taxonomy Family: Magnoliaceae
NCBI TaxonomyDB:
114509
Plant-of-the-World-Online:
n.a.
China
FFAR1; FFAR4; | |
ACHE; | |
PPARA; PPARD; PPARG; | |
ALOX15; HPGD; | |
TLR2; | |
NFKB1; | |
FABP3; LMNA; FABP2; FABP4; FABP5; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 2 | CYP2A6 | Cytochrome P450 2A6 | P11509 | CHEMBL5282 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | HPGD | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | CHEMBL1293255 |
Hydrolase | ACHE | Acetylcholinesterase | P22303 | CHEMBL220 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group C | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Nuclear hormone receptor subfamily 1 group C | PPARG | Peroxisome proliferator-activated receptor gamma | P37231 | CHEMBL235 |
Small molecule receptor (family A GPCR) | FFAR1 | Free fatty acid receptor 1 | O14842 | CHEMBL4422 |
Small molecule receptor (family A GPCR) | FFAR4 | G-protein coupled receptor 120 | Q5NUL3 | CHEMBL5339 |
Toll-like and Il-1 receptors | TLR2 | Toll-like receptor 2 | O60603 | CHEMBL4163 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | FABP2 | Fatty acid binding protein intestinal | P12104 | CHEMBL4879 |
Unclassified | FABP4 | Fatty acid binding protein adipocyte | P15090 | CHEMBL2083 |
Unclassified | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0019433; triglyceride catabolic process | 8.346E-09 | 1.069E-05 | FABP2, FABP3, FABP4, FABP5 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.611E-08 | 1.948E-05 | CYP2C19, CYP2C9, CYP2D6 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 3.043E-08 | 3.155E-05 | CYP2A6, CYP2C19, CYP2C9, CYP2D6 |
BP | GO:0050896; response to stimulus | GO:0050728; negative regulation of inflammatory response | 7.455E-08 | 6.493E-05 | FFAR4, NFKB1, PPARA, PPARD, PPARG |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 1.765E-07 | 1.325E-04 | CYP2A6, CYP2C19, CYP2C9 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 3.878E-07 | 2.815E-04 | ALOX15, CYP2A6, CYP2C19, CYP2C9, CYP2D6 |
BP | GO:0051179; localization | GO:0015908; fatty acid transport | 4.927E-07 | 3.155E-04 | FABP3, PPARA, PPARD, PPARG |
MF | GO:0003824; catalytic activity | GO:0008392; arachidonic acid epoxygenase activity | 5.439E-07 | 3.201E-04 | CYP2A6, CYP2C19, CYP2C9 |
BP | GO:0050896; response to stimulus | GO:0070542; response to fatty acid | 1.008E-06 | 5.244E-04 | FABP3, FFAR1, PPARG, TLR2 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 1.061E-06 | 5.374E-04 | CYP2A6, CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 3.298E-06 | 1.330E-03 | CYP2A6, CYP2C19, CYP2C9, CYP2D6, PPARD |
MF | GO:0005488; binding | GO:0020037; heme binding | 6.601E-06 | 2.282E-03 | CYP2A6, CYP2C19, CYP2C9, CYP2D6 |
BP | GO:0051179; localization | GO:0010891; negative regulation of sequestering of triglyceride | 9.151E-06 | 2.807E-03 | PPARA, PPARG |
BP | GO:0050896; response to stimulus | GO:0032868; response to insulin | 9.152E-06 | 2.807E-03 | FABP3, PPARA, PPARG, TLR2 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.115E-05 | 3.373E-03 | CYP2C19, CYP2C9, CYP2D6 |
BP | GO:0051179; localization | GO:0010887; negative regulation of cholesterol storage | 1.372E-05 | 3.879E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:0010871; negative regulation of receptor biosynthetic process | 1.372E-05 | 3.879E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:2001300; lipoxin metabolic process | 1.372E-05 | 3.879E-03 | ALOX15, HPGD |
MF | GO:0005488; binding | GO:0050543; icosatetraenoic acid binding | 1.372E-05 | 3.879E-03 | FABP3, PPARG |
MF | GO:0140110; transcription regulator activity | GO:0004879; nuclear receptor activity | 1.445E-05 | 3.932E-03 | PPARA, PPARD, PPARG |
BP | GO:0008152; metabolic process | GO:0009804; coumarin metabolic process | 1.919E-05 | 5.097E-03 | CYP2A6, CYP2D6 |
MF | GO:0060089; molecular transducer activity | GO:0003707; steroid hormone receptor activity | 2.533E-05 | 6.567E-03 | PPARA, PPARD, PPARG |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 4.106E-05 | 9.824E-03 | CYP2C19, CYP2C9 |
MF | GO:0060089; molecular transducer activity | GO:0004955; prostaglandin receptor activity | 4.106E-05 | 9.824E-03 | HPGD, PPARG |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 2.074E-13 | 1.659E-11 | FABP2, FABP3, FABP4, FABP5, PPARG, PPARA, PPARD |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 4.835E-07 | 1.934E-05 | CYP2C9, CYP2A6, CYP2D6, CYP2C19 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 3.385E-06 | 6.770E-05 | CYP2C9, CYP2D6, ALOX15, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 2.615E-06 | 6.770E-05 | CYP2C9, ALOX15, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 2.653E-05 | 4.245E-04 | CYP2C9, ALOX15, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 4.335E-05 | 5.780E-04 | CYP2C9, CYP2A6, CYP2D6 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 6.139E-05 | 7.016E-04 | CYP2C9, CYP2A6, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05202 | Transcriptional misregulation in cancer | 6.247E-04 | 6.247E-03 | HPGD, PPARG, NFKB1 |
09160 Human Diseases | 09161 Cancers | hsa05221 | Acute myeloid leukemia | 1.323E-03 | 1.058E-02 | NFKB1, PPARD |
09160 Human Diseases | 09167 Infectious diseases | hsa05134 | Legionellosis | 1.232E-03 | 1.058E-02 | NFKB1, TLR2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | FFAR1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | FFAR1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Non-insulin dependent diabetes | E11.9 | FFAR1; |